Cargando...
Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma
A subset of patients achieves long-term responses with sunitinib therapy. We present a retrospective study of long-term responders, defined as patients achieving durable complete response (CR) or remaining progression free for > 18 months while receiving sunitinib. Favorable risk factors associat...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3959735/ https://ncbi.nlm.nih.gov/pubmed/23707221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2013.04.001 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|